Cargando…
Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
The aim of the study was to determine the prognostic role of systemic immune-inflammation index (SII) in patients with esophageal squamous cell carcinoma (ESCC). A total of 298 ESCC patients were enrolled in the current retrospective study. The SII was calculated by the formula: neutrophil × platele...
Autores principales: | Feng, Ji-Feng, Chen, Sheng, Yang, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287956/ https://www.ncbi.nlm.nih.gov/pubmed/28121932 http://dx.doi.org/10.1097/MD.0000000000005886 |
Ejemplares similares
-
Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma
por: Yang, Chao, et al.
Publicado: (2023) -
Spindle cell carcinoma of the esophagus: A multicenter analysis in comparison with typical squamous cell carcinoma
por: Zhang, Baihua, et al.
Publicado: (2016) -
Prognostic value of preoperative systemic inflammatory response as a prognostic indicator in patients with early-stage oral squamous cell carcinoma
por: Mikami, Toshihiko, et al.
Publicado: (2022) -
Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma
por: Sun, Ming, et al.
Publicado: (2021) -
Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
por: Huang, Yihong, et al.
Publicado: (2021)